| - GRCh37:
- Chr4:26322398
- GRCh38:
- Chr4:26320776
| RBPJ | S7* | Adams-Oliver syndrome 3 | Uncertain significance (Jun 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:26407877
- GRCh38:
- Chr4:26406255
| LOC126807011, RBPJ | Y25C, Y45C, Y46C, Y47C, Y60C | Adams-Oliver syndrome 3 | Uncertain significance (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr4:26407892
- GRCh38:
- Chr4:26406270
| LOC126807011, RBPJ | R30T, R50T, R51T, R52T, R65T | Adams-Oliver syndrome 3 | Likely pathogenic (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:26432540
- GRCh38:
- Chr4:26430918
| RBPJ | E405K, E420K, E437K, E458K, E459K, E472K | Adams-Oliver syndrome 3 | Uncertain significance (Jun 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:26388004
- GRCh38:
- Chr4:26386382
| RBPJ | R15Q, R16Q, R17Q, R30Q | not provided, Adams-Oliver syndrome 3 | Uncertain significance (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:26431588
- GRCh38:
- Chr4:26429966
| RBPJ | S332R, S297R, S318R, S319R | Adams-Oliver syndrome 3 | Likely pathogenic (Dec 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr4:26417098
- GRCh38:
- Chr4:26415476
| RBPJ | F66V, F31V, F51V, F52V, F53V | Adams-Oliver syndrome 3 | Likely pathogenic (Dec 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr4:26407891
- GRCh38:
- Chr4:26406269
| RBPJ, LOC126807011 | R65G, R50G, R30G, R51G, R52G | Type II diabetes mellitus, Adams-Oliver syndrome 3 | Likely pathogenic (May 28, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:26422317
- GRCh38:
- Chr4:26420695
| RBPJ | K169E, K154E, K156E, K155E, K134E | Adams-Oliver syndrome 3 | Pathogenic (Aug 10, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr4:26407886
- GRCh38:
- Chr4:26406264
| LOC126807011, RBPJ | E63G, E48G, E28G, E49G, E50G | Adams-Oliver syndrome 3 | Pathogenic (Aug 10, 2012) | no assertion criteria provided |